Submission Details
| 510(k) Number | K013272 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 01, 2001 |
| Decision Date | October 25, 2001 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K013272 is an FDA 510(k) clearance for the ACS: 180 AND ADVIA CENTAUR THEOPHYLLINE 2 ASSAY, a Enzyme Immunoassay, Theophylline (Class II — Special Controls, product code KLS), submitted by Bayer Corp. (Tarrytown, US). The FDA issued a Cleared decision on October 25, 2001, 24 days after receiving the submission on October 1, 2001. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3880.
| 510(k) Number | K013272 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 01, 2001 |
| Decision Date | October 25, 2001 |
| Days to Decision | 24 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | KLS — Enzyme Immunoassay, Theophylline |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3880 |